Cargando…

Predictive Value of (18)F-FDG PET/CT Using Machine Learning for Pathological Response to Neoadjuvant Concurrent Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer

SIMPLE SUMMARY: The pathological complete response (pCR) after neoadjuvant chemoradiotherapy (CCRT) is an independent prognostic factor for progression-free and overall survival in non-small cell lung cancer (NSCLC). (18)F-FDG PET/CT has been performed for initial staging work-up, treatment response...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoo, Jang, Lee, Jaeho, Cheon, Miju, Woo, Sang-Keun, Ahn, Myung-Ju, Pyo, Hong Ryull, Choi, Yong Soo, Han, Joung Ho, Choi, Joon Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031866/ https://www.ncbi.nlm.nih.gov/pubmed/35454899 http://dx.doi.org/10.3390/cancers14081987

Ejemplares similares

Radiomics Analysis of (18)F-FDG PET/CT for Prognosis Prediction in Patients with Stage III Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiation Therapy Followed by Surgery
por: Yoo, Jang, et al.
Publicado: (2023)

Visualization of Dialysis-Related Amyloid Arthropathy on (18)F-FDG PET-CT Scan
por: Cheon, Miju, et al.
Publicado: (2022)

A Case Report of Early-Onset Alzheimer’s Disease Using (18)F-FDG PET and (18)F-FBB PET
por: Yoo, Jang, et al.
Publicado: (2023)

Metastatic Pulmonary Calcification Detected on (18)F-FDG PET/CT and (99m)Tc-MDP Bone Scan
por: Cheon, Miju, et al.
Publicado: (2021)

Differential diagnosis of patients with atypical Parkinsonian syndrome using (18)F-FDG and (18)F-FP CIT PET: A report of five cases
por: Yoo, Jang, et al.
Publicado: (2022)

(18)F-FDG PET/CT and Whole-Body Bone Scan Findings in Gorlin–Goltz Syndrome
por: Cheon, Miju, et al.
Publicado: (2023)

Septic Pulmonary Emboli Detected by (18)F-FDG PET/CT in a Patient with Central Venous Catheter-Related Staphylococcus aureus Bacteremia
por: Yoo, Jang, et al.
Publicado: (2022)

A Case of Chronic Neutrophilic Leukemia Incidentally Detected by (18)F-FDG PET/CT
por: Cheon, Miju, et al.
Publicado: (2021)

(18)F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy
por: Lee, Seokmo, et al.
Publicado: (2021)

(18)F-FDG PET/CT in Primary AL Hepatic Amyloidosis Associated with Multiple Myeloma
por: Son, Youn Mi, et al.
Publicado: (2011)

18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy
por: Capelli, Giulia, et al.
Publicado: (2022)

Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction
por: Zhao, Qun, et al.
Publicado: (2015)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2008)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2009)

Quantitative CT Variables Enabling Response Prediction in Neoadjuvant Therapy with EGFR-TKIs: Are They Different from Those in Neoadjuvant Concurrent Chemoradiotherapy?
por: Chong, Yousun, et al.
Publicado: (2014)

Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery
por: Shin, Sumin, et al.
Publicado: (2020)

Treatment outcomes of neoadjuvant concurrent chemoradiotherapy followed by esophagectomy for patients with esophageal cancer
por: Kim, Yong-Hyub, et al.
Publicado: (2015)

(18)F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making
por: Anderegg, Maarten C. J., et al.
Publicado: (2015)

Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using (18)F-FDG PET/CT
por: Goense, Lucas, et al.
Publicado: (2018)

Potential of (18)F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer
por: Choi, Noah C., et al.
Publicado: (2013)

Detecting Interval Distant Metastases With (18)F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

External validation of (18)F-FDG PET-based radiomic models on identification of residual oesophageal cancer after neoadjuvant chemoradiotherapy
por: Valkema, Maria J., et al.
Publicado: (2023)

Prognostic value of (18)F-FDG PET and PET/CT for assessment of treatment response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis
por: Han, Sangwon, et al.
Publicado: (2020)

Development and External Validation of (18)F-FDG PET-Based Radiomic Model for Predicting Pathologic Complete Response after Neoadjuvant Chemotherapy in Breast Cancer
por: Lim, Chae Hong, et al.
Publicado: (2023)

Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy
por: Topkan, Erkan, et al.
Publicado: (2011)

Image Registration of (18)F-FDG PET/CT Using the MotionFree Algorithm and CT Protocols through Phantom Study and Clinical Evaluation
por: Kim, Deok-Hwan, et al.
Publicado: (2021)

Prognostic Significance of Volumetric Parameters Based on FDG PET/CT in Patients with Lung Adenocarcinoma Undergoing Curative Surgery
por: Lee, Hyunjong, et al.
Publicado: (2023)

Prediction of Non-Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients with (18)F-FDG PET Radiomics Based Machine Learning Classification
por: Beukinga, Roelof J., et al.
Publicado: (2022)

(18)F-FDG-PET/CT-measured parameters as potential predictors of residual disease after neoadjuvant chemoradiotherapy in patients with esophageal carcinoma
por: Tustumi, Francisco, et al.
Publicado: (2022)

FDG PET using SUV(max) for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy
por: Huang, Yung-Cheng, et al.
Publicado: (2017)

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
por: Setakornnukul, Jiraporn, et al.
Publicado: (2018)

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients with cervical nodal necrosis
por: Lan, Mei, et al.
Publicado: (2017)

Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma
por: Jung, Jang Han, et al.
Publicado: (2017)

Prognostic Significance of Pseudotime from Texture Parameters of FDG PET/CT in Locally Advanced Non-Small-Cell Lung Cancer with Tri-Modality Therapy
por: Lee, Hyunjong, et al.
Publicado: (2022)

The Impact of (18)F-FDG PET CT Prior to Chemoradiotherapy for Stage III/IV Head and Neck Squamous Cell Carcinoma
por: Prestwich, Robin J. D., et al.
Publicado: (2012)

EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
por: Park, Song Ee, et al.
Publicado: (2019)

Prediction of response by FDG PET early during concurrent chemoradiotherapy for locally advanced non-small cell lung cancer
por: Kim, Suzy, et al.
Publicado: (2014)

Prospective Analysis of (18)F-FDG PET/CT Predictive Value in Patients with Low Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy and Conservative Surgery
por: Niccoli-Asabella, Artor, et al.
Publicado: (2014)

Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?
por: Deantonio, Letizia, et al.
Publicado: (2018)

Diffusion-weighted MRI and (18)F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
por: Xu, Xin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mb8h4t2b53eek7f1mrodfc26kj